Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). OC-057 A PH3 Randomised, Multicenter, Double-Blind, Placebo (PBO)-Controlled Study of Ustekinumab (UST) Maintenance Therapy in Moderate–Severe Crohn's Disease (CD) PTS: Results from IM-UNITI. Gut. pp. A32-A34. [Online].